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Type I interferon inhibits varicella-zoster 
virus replication by interfering with the dynamic 
interaction between mediator and IE62 
within replication compartments
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Abstract 
Background: Varicella‑zoster virus (VZV) is the causative agent of varicella and zoster. The immediate‑early protein, 
IE62 is the predominant VZ virion tegument protein, transactivating the expression of all kinetic classes of VZV genes. 
IE62 is localized to punctae that form DNA replication compartments in the nuclei of VZV infected cells. The mor‑
phological changes and the increase in the size of replication compartments that express IE62 are correlated with 
production of VZ virions. Mammalian Mediator serves as a coactivator of IE62 and functions by bridging DNA‑binding 
transcription factors¸ RNA polymerase II (RNAP II) and their target DNAs for VZV replication. While VZV is highly sensi‑
tive to type I interferons (IFNs), how IFN‑α inhibits early events during VZV replication is poorly understood.
Results: In this study, we performed in situ analysis to investigate the effects of IFN‑α on the dynamic interactions of 
IE62 with the Mediator MED25 subunit and the RNAP II negative regulator cycle‑dependent kinase 8 (CDK8) in VZV 
infected cells by confocal immunofluorescence. We found that in addition to dose‑dependent inhibition of the yields 
of infectious virus by IFN treatment, IFN‑α prominently impeded the development of large IE62+ nuclear compart‑
ments and significantly decreased transcription of VZV genes. Both the expression level and stable recruitment of 
MED25 to IE62+ replication compartments were inhibited by IFN‑α. While IFN‑α treatment upregulated CDK8 expres‑
sion, redistribution and recruitment of CDK8 to IE62+ replication compartments in infected cells was not affected by 
VZV.
Conclusion: IFN‑α exerts multiple inhibitory activities against virus infections. In this study, we provide visionary 
demonstration that continuous translocation of MED25 into VZV replication compartments ensures production of viri‑
ons. IFN‑α greatly impedes the formation of a stable complex between IE62 and the Mediator complex thereby sup‑
presses VZV gene transcription. Our demonstration that IFN‑α‑induced antiviral effect against VZV infection is through 
inhibiting the reorganization of nuclear components uncovers a novel function of IFN‑α. Targeting the interaction 
between IE62 and MED25 may offer a novel approach to the development of antiviral agents against VZV infection.
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Background
Varicella-zoster virus (VZV) is an alphaherpesvirus. It 
has a double-stranded DNA genome of about 125,000 
base pairs which encodes for at least 70 unique open 
reading frames (ORFs). Primary VZV infection causes 
varicella (chickenpox) characterized by viremia and skin 
lesions. VZV can be reactivated in sensory ganglia from 
latency to cause zoster (shingles) [1].
Type I interferons (IFNs) including IFN-α and IFN-β 
constitute a potent innate defense system against virus 
infections [2]. IFN-α treatment dose-dependently inhibits 
the production of VZV in human foreskin fibroblast cells 
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[3] and the expression of VZV immediate-early, early and 
late proteins are suppressed in IFN-α treated cells [4]. We 
have previously demonstrated that IFN-α is induced in 
uninfected epidermal keratinocytes that surround VZV 
lesions. Blocking IFN-α/β receptor-mediated signaling 
enhances VZV replication and promotes viral spread in 
human skin xenografts in severe combined immunode-
ficiency (SCID) mice [5]. While IFN-induced activation 
of antiviral protein kinase R correlates with inhibition of 
VZV replication [6], how IFN-α inhibits early events of 
VZV replication is poorly understood.
VZV immediate-early (IE) 62 acts to induce the expres-
sion of other immediate early (IE), early (E), and late (L) 
VZV genes before any other viral proteins are synthe-
sized [1]. It is reported that Mediator, a multi-subunit 
coactivator of RNA polymerase II (RNAP II) serves as co-
activator for VZV IE62 to transactivate genes during lytic 
VZV infection. Mediator is a global transcription regula-
tor conserved in yeast and mammalian cells [7]. Physical 
interaction of VZV IE62 with the Mediator 25 (MED25) 
subunit is required for IE62 transactivation activity [8].
Single cell analysis of VZV-infected cells showed that 
VZV DNA initially accumulates in small punctae near 
the nuclear rim. The DNA punctae increase in size as 
viral DNA replicates and acquires a globular pattern over 
time. IE62 is found to localize in large DNA punctae as 
well as the globular structures [9]. The facts that IE62 
recruits cellular transcription factors and RNAP II to 
the TATA sites within the VZV promoters [10] and that 
MED25 enhances IE62 transactivation activity led us to 
investigate whether IFN-α might interfere with VZV rep-
lication through inhibiting MED25 recruitment to IE62-
expressing replication compartments.
While MED25 positively activates gene transcrip-
tion, the 4-subunit CDK8 module (consisting of cell 
cycle-dependent kinase 8 (CDK8), cyclin C, MED12 and 
MED13) sterically blocks the interaction of Mediator with 
RNAP II and regulates RNAP II-dependent transcrip-
tion initiation [11, 12]. It was recently reported that type 
I and type II IFNs induce nuclear expression of CDK8 
[13]. Since VZV gene expression is RNAP-II dependent 
and IE62 inhibits TANK-binding kinase (TBK-1) activity, 
which results in the blockage of IFN-β production [14], it 
is of interest to know whether IFN-α treatment induces 
CDK8 expression and whether VZV infection suppresses 
IFN-α-induced CDK8 expression and distribution.
The highly cell-associated nature of VZV replication is 
a primary obstacle to studies of the early events during 
VZV replication in newly infected cells. Since only low 
titers of cell-free VZV can be recovered from infected 
cells in culture, synchronous infection is not possible. 
Using infected cells as inoculum results in the presence 
of both inoculum cells and newly infected cells which 
are indistinguishable by using viral protein expression as 
markers. However, fluorescent dye labeled inoculum cells 
coupled with confocal immunofluorescence microscopic 
analysis made it possible to document the spatiotemporal 
expression of major VZV proteins [9]. The advancement 
in microscopy technology by digitalizing fluorescence 
intensity allows comparisons of protein expression in 
subcellular localizations in tissue sections as well as cul-
tured cells [15–17]. Taking advantage of these technolo-
gies, we did in  situ analysis to investigate the effects of 
IFN-α on the dynamics of MED25 and CDK8 distribution 
in IE62-expressing replication compartments. We found 
that stable recruitment of MED25 to VZV replication 
compartments positively correlated with the progressive 
development of IE62-expressing large and large globu-
lar punctae in VZV-infected cells. VZV gene transcrip-
tion, the size of IE62-expressing nuclear compartments 
and recruitment of MED25 to the replication compart-
ments were all reduced in IFN-α treated cells. Interest-
ingly, IFN-α treatment upregulated CDK8 expression 
although CDK8 redistribution and recruitment to IE62+ 
replication compartments in VZV infected cells was not 
affected. Our findings reveal that IFN-α treatment inter-
feres with intranuclear redistribution of Mediator and 
blocks VZV gene transcription.
Results
IFN‑α treatment inhibits IE62 expression in VZV‑infected 
HELF cells
Primary human embryonic lung fibroblast (HELF) mon-
olayers were pretreated with different concentrations of 
IFN-α before addition of green fluorescent dye CFSE-
labeled VZV-infected cells. Confocal microscopic analysis 
showed that CFSE+ VZV inoculum cells were surrounded 
by newly infected cells expressing IE62 (Fig.  1a). IFN-α 
treatment reduced nuclear IE62 expression in the 
VZV-infected monolayers in a dose dependent manner 
(Fig. 1a). Typical large VZV plaques with syncytia forma-
tion were not observed in IFN-α treated monolayers. The 
percentage of IE62+ cells was 59 % without treatment and 
was reduced to 32, 28 and 6.7  % with treatment of 300, 
1000, 10,000 U/ml of IFN-α, respectively (Fig.  1b). High 
dose of IFN-α significantly inhibited the initiation of 
infection by IE62 expression in VZV infected cells.
IFN‑α treatment effectively inhibits IE62‑dependent 
expression of VZV genes of all classes and reduces the 
production of infectious virions
To quantify the effect of IFN-α on VZV gene transcription, 
we analyzed seven VZV genes that are otherwise normally 
expressed during immediate early (IE) (ORF4, ORF61 
and ORF62), early (E) (ORF28 and ORF51) and late (L) 
(ORF23, ORF68) phases of infection [1, 4]. Quantitative 
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RT-PCR results showed that while ORFs 4, 61, 62, 28, 51, 
23, and 68 were abundantly expressed at 12 and 24 h after 
VZV infection, IFN-α treatment reduced the levels of VZV 
IE (ORFs 4, 61 and 62) transcripts by two–threefold at 
12 h, and remained low at 24 h after treatment (p < 0.001) 
(Fig. 2a). Early and late genes transcripts including ORFs 
28, 51, 23, and 68 were also reduced significantly in IFN-α 
treated cells compared to untreated VZV-infected HELF 
over the 24  h time course (p  <  0.001) (Fig.  2b, c). These 
experiments demonstrated that IFN-α effectively inhibits 
IE gene transcription and the subsequent expression of 
VZV genes of all classes. Viral yields from IFN-α treated 
cells were also reduced in a dose dependent manner com-
pared to untreated cells (Fig.  2d). These results showed 
that IFN-α treatment inhibits IE62-dependent VZV gene 
expression and reduced the production of progeny virions.
IFN‑α blocks the progressive development 
of IE62‑expressing replication compartments from small 
and large to large gobular patterns
Nuclear IE62 is known to translocate and accumulate in 
the cytoplasm in VZV-infected cells at late stage of infec-
tion [18]. We analyzed IE62 expression patterns while 
IE62 still remained in the nuclei of VZV-infected cells. 
IE62 appears at nuclear membranes early in VZV replica-
tion and IE62-expressing nuclear domains increase in size 
and change in morphology as viral DNA transcription 
proceeds [9]. We utilized the changing morphology of 
IE62 nuclear expression patterns as an indicator to study 
the effect of IFN-α on VZV replication compartments at 
the single cell level. In VZV-infected cells, IE62 accumu-
lated initially in distinct small (<3.2  μm2/area) and large 
(3.2–16  μm2/area) punctae forms and changed to large 
globular pattern (>16  μm2/area) as infection progressed 
(Fig.  3a). There was no difference in the distribution of 
the small, large punctae and large globular pattern of IE62 
expression between IFN-α-treated and untreated cells at 
12  h (Fig.  3b, c). However, IFN-α treatment significantly 
inhibited the progression of IE62-expressing foci from 
small to large punctae and the large globular pattern by 
24 h, and there was a high percentage of uninfected cells in 
the monolayer (Fig. 3b). Importantly, while the percentage 
of IFN-α-treated cells (45 ±  5.01  %) that expressed IE62 
was comparable to untreated cells (49.75 ± 7.3 %) at 12 h, 
it was significantly lower (26.0  ±  1.4  %) than untreated 
cells (80.8  ±  5.9  %) at 24  h (P  <  0.01) (Fig.  3c). These 
experiments show that IFN-α pretreatment had significant 
impact on the development of VZV replication compart-
ments but not on the initiation of IE62 expression.
IFN‑α treatment blocks the stable recruitment of MED25 
into IE62‑expressing replication compartments
Nuclear protein MED23 and MED25 are subunits of the 
mammalian Mediator complex known to be associated 
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Fig. 1 Dose dependent effects of IFN‑α on IE62 expression. Primary human embryonic fibroblasts (HELFs) were untreated or treated with IFN‑α at 
300, 1000 or 10,000 U/ml for 24 h followed by inoculation of green fluorescent dye CFSE‑labeled VZV infected cells. a The cell monolayer was fixed 
at 24 h, stained with primary antibody to VZV IE62 and detected with donkey anti‑rabbit IgG (red). Green stained cells were inoculated VZV‑infected 
cells. Cells were counterstained with DAPI and analyzed by confocal microscopy. Shown are representative illustrations from at least three inde‑
pendent experiments. Scale bar 100 μm. b IE62 positive cells were counted for each group of cells in the total of 20–200 cells in the same coverslip. 
The percentages of cells that expressed IE62 were thus calculated. Shown is the average from two independent experiments with error bars
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Fig. 2 IFN‑α inhibits VZV gene expression. Expression of selected VZV genes representing immediate‑early (a), early (b) and late (c) genes in 
untreated or IFN‑α treated HELFs at 12 and 24 h after incubation with VZV infected cells was measured by quantitative real‑time PCR. Expression 
of each gene at 12 and 24 h was normalized to the expression of Gapdh. The levels of expression were calculated by fold increase compared to 
the corresponding gene expressed in cells at 0 h in which cells were harvested immediately after inoculation with VZV infected cells. Each bar 
represents the mean ± SEM of triplicate measurements from one representative of two independent experiments. The difference in expression of 
each gene expressed in untreated and IFN‑α treated cells at 12 or 24 h was compared by Student’s t test. d Virus yields from untreated cells or cells 
treated with varying concentrations of IFN‑α were evaluated by infectious focus assay at 24 h post infection. Each bar represents the mean ± SEM 
of triplicate titrations from three independent experiments (unpaired Student’s t test). (**p < 0.01; ***p < 0.001; not significant (n.s.), p > 0.05)
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with the IE62-mediated transcriptional complex [19]. 
Confocal immunofluorescence analysis showed that 
MED23 which is typically diffuse in nuclei redistributes 
during the early phase of VZV infection to a pattern 
that overlapped completely with IE62. MED23 returns 
to a diffuse nuclear distribution in the late phase when 
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IE62 is translocated to the cytoplasm [20]. To investigate 
the effect of IFN-α on the dynamic interaction between 
IE62 and the Mediator subunit, we studied the redistri-
bution of MED25 to IE62 compartments and quantified 
its expression level in untreated and IFN-α treated cells. 
Similar to MED23, VZV infection induced MED25 redis-
tribution and translocation to IE62-expressing nuclear 
domains (Fig.  4a, b). While MED25 protein colocal-
ized with IE62 punctae in small, large and large globu-
lar morphological forms, MED25 was more prominent 
in large punctae and large globular foci (Fig.  4a). Inter-
estingly, while MED25 redistribution was also observed 
in the nuclei of IFN-α treated IE62-expressing cells, the 
level of MED25 that co-localized with IE62 was much 
reduced (Fig.  4b). Med25 mRNA was stably expressed 
in untreated and VZV-infected cells over the first 24  h 
after infection. While IFN-α treatment did not affect 
Med25 mRNA transcription in uninfected cells, it signifi-
cantly reduced Med25 expression at 12 h and increased 
its expression at 24 h after VZV infection (Fig. 4c). Single 
cell analysis shows that MED25 expression was reduced 
in IFN-α-treated cells without VZV infection (Fig.  4d). 
The level of MED25 in IE62+ compartments was 
increased and its intensity increased as the size of IE62+ 
foci increased (Fig.  4d). With IFN-α treatment, while 
there was an increase of MED25 in small IE62+ punctae, 
the intensity of MED25 in the large globular IE62+ foci 
was significantly lower than in untreated cells (Fig.  4d). 
These results indicate that VZV replication is associated 
with translocation of MED25 and its stable and continu-
ous presence in IE62+ replication compartments. IFN-α 
is likely to interfere with VZV replication by inhibiting 
its co-localization with IE62 in replication compartments 
rather than inhibiting transcription of Med25 gene, thus 
impairing the progression of VZV infection.
IFN‑α increases nuclear CDK8 expression and its 
association with IE62‑expressing replication 
compartments
We studied the interaction between CDK8 with IE62 
and the effects of IFN-α treatment in VZV-infected cells. 
Confocal microscopic analysis shows that CDK8 was 
redistributed and recruited to IE62+ replication com-
partments upon infection whether or not cells were pre-
treated with IFN-α (Fig. 5a). There was no difference in 
CDK8 distribution and association with IE62 in infected 
cells with or without IFN-α treatment (Fig. 5b). Expres-
sion of Cdk8 mRNA was significantly upregulated by 
IFN-α treatment and remained stable after VZV infection 
(Fig.  5c). Single cell analysis shows that CDK8 expres-
sion was enhanced in IFN-α treated cells before VZV 
infection (Fig.  5d). It is interesting to note that CDK8 
was also recruited to IE62 compartments in infected but 
untreated cells (Fig. 5d). Our data demonstrate that while 
CDK8 expression is induced by IFN-α treatment and 
translocation of CDK8 into IE62+ replication compart-
ments in VZV-infected cells occurs regardless of IFN-α 
treatment, further investigation is required to define the 
role for CDK8 in VZV infection.
Discussion
In this study, we analyzed expression and intranuclear 
localization of the IE62 major transactivating protein of 
VZV and the cell proteins, MED25 and CDK8 at a sin-
gle cell level in order to better understand how IFN-α 
impairs VZV replication. IFN-α treatment impaired the 
progression of IE62-expressing compartments from small 
to large globular punctae in VZV-infected cells, which 
was associated with a reduction of transcription of all 
kinetic classes of VZV genes. While MED25 was dra-
matically re-localized to VZV replication compartments 
in VZV-infected cells, IFN-α treatment interfered with 
this process. Interestingly, CDK8 was redistributed and 
recruited to IE62+ replication compartments upon VZV 
infection whether or not cells were pretreated with IFN-α 
and IFN-α treatment upregulated CDK8 expression over-
all. This study indicates that IFN-α inhibits VZV gene 
expression, virus spread in monolayers and production 
of progeny virus particles by interfering with the intranu-
clear redistribution of Mediator to IE62-expressing repli-
cation compartments.
We have previously reported that IFN-α induc-
tion inhibits VZV spread and formation of lesions in 
human skin xenografts in SCID mice in vivo [5]. We also 
(See figure on previous page.) 
Fig. 3 IFN‑α affects the size and morphology of IE62‑expressing replication compartments. a Three representative cells from confocal microscopy 
images illustrate small punctate (<3.2 μm2), large punctate (3.2–16 μm2) or large globular pattern (>16 μm2) based on IE62 staining. Scale bar 5 μm. b 
Untreated or IFN‑α treated HELF cell monolayers at 12 and 24 h post VZV infection were stained with anti‑IE62 antibody. Shown are two representa‑
tive fields from microscopic confocal images and illustrate that IFN‑α treatment inhibits the progression of large globular replication compartments 
compared with untreated cell monolayer. Scale bar 10 μm. c Confocal microscopic images from 20 fields of IE62 stained cell monolayers from two 
independent experiments were analyzed for the size and morphology of IE62‑expressing replication compartments. 30–90 untreated and IFN‑α 
treated cells at 12 or 24 h post VZV inoculation were analyzed. Each bar represents the mean percentage of total cells, which were uninfected, or IE62 
positive cells expressing small, large or large globular morphology. Differences in IE62 expression between untreated and IFN‑α treated cells were 
tested by unpaired Student’s t test
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observed that VZV proteins were expressed in epider-
mal cells within VZV lesions but not in the neighboring 
keratinocytes. The in  situ single cell analysis data pre-
sented here showed that while IFN-α treatment did not 
affect the initiation of IE62 expression, it suppressed 
the development of globular VZV replication compart-
ments. It is our speculation that inhibition of the matu-
ration of replication compartment that is associated 
with productive infection is likely the mechanism of how 
IFN-α causes restricted viral gene transcription.
The cell Mediator complex governs eukaryotic gene 
transcription through extensive interactions with RNAP 
II and both general and gene-specific transcription fac-
tors [21]. The pull-down assays showed that MED25 is 
the cell substrate targeted by the IE62 activation domain 
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Fig. 4 IFN‑α reduces nuclear MED25 expression and interferes with its redistribution to IE62‑expressing replication compartments. Untreated or 
IFN‑α treated HELF monolayers were fixed in 4 % PFA at 12 or 24 h post VZV inoculation. The cell monolayers were double stained with anti‑MED25 
(green) and anti‑IE62 (red) antibodies for confocal microscopic analysis. Representative double immunofluorescence stained single cells from 
untreated (a) or IFN‑α treated (b) illustrated MED25 expression in IE62‑expressing replication compartments in small, large or large globular pattern. 
Arrows shown in merged images indicate colocalization of IE62 and MED25. c Expression of Med25 mRNA in untreated or IFN‑α‑treated HELFs at 12 
and 24 h after incubation with VZV‑infected or mock‑infected cells was measured by qRT‑PCR. The level of expression was normalized to the expres‑
sion of human β‑actin and expressed as relative expression to human β‑actin. Each bar represents the mean ± SEM of triplicate measurements from 
one experiment. d MED25 integrated intensity from each cell was measured by MetaMorph software. The averages of MED25 integrated inten‑
sity in untreated (white bars) or IFN‑α treated cells (black bars) without VZV inoculation or with VZV infection are shown in (d). MED25 integrated 
intensity expressed in the nucleus of uninfected HELF cells was measured based on DAPI stain. The averages of MED25 integrated intensity for 
IE62‑expressing cells in various morphological forms in untreated or IFN‑α treated cells are shown. Each bar represents the mean ± SEM of MED25 
integrated intensity from 14–16 cells (untreated group) or 20–30 cells (IFN‑α treated group) analyzed. Differences between each groups were tested 
by unpaired Student’s t test (**p < 0.01; ***p < 0.001; not significant (n.s.), p > 0.05). Scale bar 5 μm
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interaction between MED25 and IE62 and inhibited the 
IE62-mediated promoter activity [8]. Our results dem-
onstrated that stable recruitment of MED25 to IE62-
expressing compartments ensures productive VZV 
replication. With regard to IFN-α suppression of VZV, we 
found that transcription of Med25 is decreased in IFN-α 
treated cells after VZV infection despite that the antiviral 
response does not block the translocation of MED25 to 
small IE62 punctae. However, IFN-α significantly hinders 
continuous recruitment of MED25 to IE62-expressing 
replication compartments. Thus, IFN-α has the capacity 
to inhibit VZV infection by impairing the formation of 
replication compartments and blocking MED25 translo-
cation to these compartments where viral gene transcrip-
tion occurs in newly infected cells.
Reorganization of viral and cellular macromolecules 
within the nucleus of infected cells to form replica-
tion compartments provides a platform which ensures 
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Fig. 5 IFN‑α increases nuclear CDK8 expression and its association with IE62‑expressing replication compartments. Untreated or IFN‑α treated 
HELF monolayers were fixed in 4 % PFA at 12 or 24 h post VZV inoculation. The cell monolayers were double stained with anti‑CDK8 (green) and 
anti‑IE62 (red) antibodies for confocal microscopy analysis. Representative double immunofluorescence stained single cells from untreated (a) or 
IFN‑α treated (b) illustrated CDK8 expression in IE62‑expressing replication compartments in small, large or large globular pattern. Arrows shown 
in merged photographs indicate colocalization of IE62 and CDK8. c Expression of Cdk8 mRNA in untreated or IFN‑α treated HELFs at 12 and 24 h 
after incubation with VZV‑infected or mock‑infected cells was measured by qRT‑PCR. The level of expression was normalized to the expression of 
human β‑actin and expressed as relative expression to human β‑actin. Each bar represents the mean ± SEM of triplicate measurements from one 
experiment (unpaired Student’s t test). d CDK8 integrated intensity from each cell was measured by MetaMorph software. The averages of CDK8 
integrated intensity in untreated (white bars) or IFN‑α treated cells (black bars) without VZV inoculation or with VZV infection are shown in (d). 
CDK8 integrated intensity expressed in the nucleus of uninfected HELF cells was measured based on DAPI stain. The averages of CDK8 integrated 
intensity for IE62+ cells in various morphological forms in untreated or IFN‑α treated cells are shown. Each bar represents the mean ± SEM of CDK8 
integrated intensity from 20–40 cells (untreated group) or 20–55 cells (IFN‑α treated group) analyzed. Differences between each group were tested 
by unpaired Student’s t test (**p < 0.01; ***p < 0.001; not significant (n.s.), p > 0.05). Scale bar 5 μm
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efficient viral replication for DNA viruses [22]. Like in 
other herpesviruses, transcription of VZV genome dur-
ing lytic infection requires binding of RNAP II and 
other cellular transcription factors to IE promoters [10]. 
Although pull-down assays showed that the CDK8 mod-
ule is excluded from IE62-interacting Mediator com-
plex [8], we observed that VZV induces transcription 
of Cdk8 mRNA and CDK8 is redistributed and translo-
cated to IE62-expressing replication compartments in 
VZV-infected cells. These results suggest that CDK8 is 
involved in VZV replication. CDK8-dependent phos-
phorylation of host transcription factors is known to 
repress their transactivation activity [23, 24]. CDK8 does 
not directly bind to IE62. We observed that VZV infec-
tion triggers the redistribution of CDK8 to replication 
compartments even though it does not bind to IE62. The 
presence of CDK8 in replication compartments might 
play a role in shifting transcription from cellular genes 
to viral genes. Bancerk et al. showed that nuclear expres-
sion of CDK8 is important to both type I and type II IFN 
responses [13]. Our data show that IFN-α treatment 
reduced MED25 expression but increased that of CDK8. 
CDK8 nuclear redistribution occurred to VZV-infected 
cells with or without IFN-α treatment. Since MED25 and 
CDK8 reversibly bind to RNAP II [25], it is possible that 
reduced MED25 expression after IFN-α treatment may 
be important in keeping CDK8 in a functional state to 
inhibit viral replication. Further investigation of the role 
of CDK8 in VZV infection and in the IFN-α-mediated 
antiviral response is warranted.
The function of Mediator complex in the VZV repli-
cation has been demonstrated mainly by biochemical 
experiments [8, 19]. The molecular components of VZV 
replication compartments have been less well defined. 
The demonstration of temporal increase in the size of 
VZV DNA domains overlapping with IE62 expression 
[9] has prompted us to investigate the interactions of 
major viral transactivator IE62 and the Mediator com-
plex within the VZV replication compartments. In this 
study, we provide visionary demonstration that continu-
ous translocation of MED25 is essential for the matura-
tion of VZV replication compartments. IFN-α treatment 
impedes the development of replication compartment 
partly through blocking the formation of a stable com-
plex between IE62 and the Mediator complex thereby 
impairing viral replication. Our demonstration that 
IFN-α-induced antiviral effect against VZV infection is 
through inhibiting the reorganization of nuclear compo-
nents uncovers a novel function of IFN-α. Targeting the 
interaction between IE62 and MED25 could represent a 
novel strategy to identify antiviral drugs for treating VZV 
infections.
Conclusions
The antiviral effects of type I IFN has been extensively 
studied since it was first described by Isaacs and Linden-
mann more than 50  years ago [26]. Type I IFN induces 
over 300 interferon-stimulated genes in treated cells and 
most of which interfere virus replication at the transcrip-
tion and translation levels [27]. However, studies of the 
impacts of IFN-induced antiviral state on virus replica-
tion in  situ are limited. With the advancement in digi-
tal microscopy technology, we investigated the dynamic 
interaction between viral transcription factor IE62 and 
Mediator within viral replication compartments at sin-
gle cell level. Formation of a stable complex between 
IE62 and MED25 positively correlates with the matu-
ration of replication compartments and production of 
VZV. IFN-α treatment significantly inhibits the develop-
ment of mature replication compartments and impedes 
subsequent VZV gene transcription (as summarized in 
Fig. 6). Our study uncovers a novel function of IFN-α. We 
demonstrate that IFN-α-induced antiviral effect against 
VZV infection is through inhibiting the reorganization of 
nuclear components. Results from this study suggest that 
disruption of viral replication compartment by targeting 
the interaction between MED25 and IE62 has therapeu-
tic potential for treating VZV infection.
Methods
Viruses, viral propagation and IFN‑α treatment
Primary human embryonic lung fibroblasts (HELFs) were 
maintained in Minimal Essential Medium plus 10  % fetal 
calf serum and antibiotics. A clinical VZV isolate, strain S 
[28] was propagated in HELFs used at a maximal passage of 
15–17 as previously described [29]. The virus stocks were 
stored in freezing medium with 10 % DMSO at −70 °C.
VZV-infected HELF were used to infect HELF mon-
olayers at ratios of 1:1 or 1:10 infected to uninfected cells. 
The HELF monolayers were either left untreated or pre-
treated with recombinant human IFN alpha 2 (IFN-α) 
(Roferon®-A, Roche Diagnostics, IN) at 10,000 U/ml for 
24 h before infection. Viral titers were assessed as previ-
ously described [5].
Immunofluorescence and confocal microscopy
Methods using fluorescent dye to label the viral inoculum 
cells to differentiate the VZV infected inoculum (input 
cells) and the newly infected cells were modified from the 
previous study [9]. Briefly, 5 μM of the green membrane 
permeant fluorescent dye 5(6)-carboxyfluorescein diac-
etate N-succinimidyl ester (CFSE, Sigma-Aldrich) was 
added to a heavily infected HELF monolayer and incu-
bated at 37  °C for 15  min. The succinimidyl side chain 
of CFSE is coupled to the amino groups of intracellular 
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proteins via a very stable amide bond and achieves sta-
ble labeling of the cells because of the long-lived conju-
gates [30]. Labeled cells were washed in PBS, dispersed 
with trypsin, resuspended in PBS and used as inoculum 
cells. For infection, HELF were seeded onto sterile glass 
coverslips and incubated with labeled inoculum cells 
at a multiplicity of infection of one infected cell per 10 
uninfected cells. Coverslips were incubated on ice for 
30 min to allow the input cells to settle on the monolayer 
and then transferred to 37  °C to initiate infection. The 
primary antibodies used for immunofluorescence stain-
ing included mouse monoclonal antibodies against IE62 
(H6), CDK8 (Bethyl Laboratories, Montgomery, TX) and 
MED25 (Thermo Scientific, Rockford, IL). For immuno-
fluorescent staining, cells were fixed in 4 % paraformalde-
hyde (PFA) at 24 h, permeabilized with 2 % PFA + 0.2 % 
Triton X-100 at RT for 30  min, washed, and stained 
with primary antibodies at RT for 1 h. Primary antibod-
ies were diluted in PBS with 1  % fish gelatin as follows: 
anti-IE62 (H6), 1:250; anti-CDK8, 1:500; anti-MED25, 
1:50. After washing, cells were stained with AlexaFluo 
488 (green) or AlexaFluo 555 (red)-conjugated secondary 
antibody (Life Technologies, Calsbad, CA). Fluorescence 
signals and the images were visualized and captured with 
a Leica SP5 confocal microscope system using HCX PL 
APO CS 100× NA 1.4 oil immersion planapochroma-
tive objectives with zoom 2× at Imaging Core facility, 
Genomic Research Center, Academia Sinica.
Digital image analysis
The fluorescence intensity from the region of interest 
(ROI) of confocal images was measured using Meta-
Morph software. Results were expressed as ROI intensity 
per μm2 area and plotted in Prizm software. Significant 
differences in the fluorescence intensity of ROI were 
tested by Student’s t test.
Quantitative real‑time RT‑PCR (qRT‑PCR) for gene 
transcription
Total RNA was extracted from HELF (2 ×  106) at 0, 12 
and 24 h after VZV inoculation using Trizol reagent (Inv-
itrogen). The RNA samples were treated with TURBO™ 
CDK8 
TFIID 
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a VZV infection in untreated cells VZV infection in IFN- -treated cells b 
Fig. 6 Speculative mechanism on how IFN‑α inhibits VZV via interference of Mediator and IE62 within replication compartments. a During VZV 
infection, the major transactivator IE62 interacts with RNAP II, cellular transcription factor (TF) IID (TFIID), and the basal transcription complex which 
together form the replication compartment (RC) for viral DNA replication. Efficient VZV gene transcription requires recruitment of Mediator complex 
through IE62 and MED25 interaction which stabilizes RNAP II activity. Continuous translocation of MED25 into VZV RCs is essential for RC maturation 
(large globular pattern) and virion production. b IFN‑α treatment impedes the formation of a stable complex between IE62 and Mediator complex, 
thus blocks RC maturation (small and large punctae). IFN‑α induces the expression of CDK8 whose presence in RC may further inhibit the interac‑
tion between MED25 and IE62. Targeting the interaction between IE62 and MED25 (indicated by dashed arrow in a) may offer a novel approach to 
the development of antiviral agents against VZV infection
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DNA-free kit (Ambion) to remove genomic DNA accord-
ing to the manufacturer’s instructions. The first strand 
of cDNA was synthesized from 2  μg of DNase treated 
RNA by random hexamer and M-MLV reverse tran-
scriptase (Invitrogen). Primer sets used to amplify VZV 
genes were as follows. ORF4: 5′-CCACGGGAGAA 
AGAAATGAT-3′ and 5′-CGTACCGAGT CAATGGTC 
AC-3′; ORF23: 5′-ATAGGGACAGTCTCGGCAAA-3′ 
and 5′-GCTGATG CCAGAAGCATTTA-3′; ORF28: 
5′-TCTGTGGCGCTCAATAACCTC-3′ and 5′-TACTT 
GCCGAGTGTTTACGC-3′; ORF51: 5′-TGTGTACAT 
ACGCGGGAGTT-3′ and 5′-CGTA CATCCTCGTG 
TTCAGG-3′; ORF61: 5′-TTCGGATAATACCTGCACC 
A-3′ and 5′-AGCAGAAGTCGTGCAAACAC-3′; ORF62: 
5′-CAGACGATCATGTGGTTTCC’ and 5′-CGTCAAG 
TGGCATCGTTATT-3′; ORF68: 5′-CCCAAGGCCAAA 
GACTCA-3′ and 5′-TGCGTCTCCCGTACAGGTTA-3′. 
Primer sets for Med25 are 5′-CAGCAGTCAGTCTCCAA 
TAAG-3′ and 5′- TTCTCGCCATGATTCACG-3′; Cdk8: 
5′-TTGGAGCAAGGCATTATACC-3′ and 5′-AGCATG 
TGGATTGGAACG-3′. Quantitative real-time reverse 
transcription PCR (qRT-PCR) amplification was per-
formed using a Bio-Rad iCycler iQTM optical (one cycle 
of 94 °C for 5 min for the pre-denaturation step; 45 cycles 
of 94 °C for 30 s and 60 °C for 1 min) for VZV genes or 
using ABI 7900HT Real-Time PCR System (Applied Bio-
systems) (one cycle of 95 °C for 2 min for the pre-dena-
turation step; 40 cycles of 95 °C for 5 s and 60 °C for 30 s) 
for med25 and cdk8 genes at the First Core Research Lab-
oratory, NTU. Relative expression of the qRT-PCR prod-
uct was determined with the comparative 2−ΔΔCt method 
after normalization to Gapdh mRNA (for VZV genes) 
or human β-actin mRNA (for Med25 and Cdk8 genes) 
expression.
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